{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:24:38Z","timestamp":1793064278444,"version":"4.5.0"},"reference-count":37,"publisher":"Massachusetts Medical Society","issue":"17","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research & Development, LLC, a Johnson & Johnson company.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2025,10,30]]},"DOI":"10.1056\/nejmoa2503001","type":"journal-article","created":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T06:47:12Z","timestamp":1757227632000},"page":"1681-1693","source":"Crossref","is-referenced-by-count":155,"title":["Overall Survival with Amivantamab\u2013Lazertinib in\n                    <i>EGFR<\/i>\n                    -Mutated Advanced NSCLC"],"prefix":"10.1056","volume":"393","author":[{"given":"James Chih-Hsin","family":"Yang","sequence":"first","affiliation":[{"name":"National Taiwan University Cancer Center, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8787-5587","authenticated-orcid":false,"given":"Hidetoshi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enriqueta","family":"Felip","sequence":"additional","affiliation":[{"name":"Medical Oncology Service, Vall d\u2019Hebron Institute of Oncology, Vall d\u2019Hebron Barcelona Hospital Campus, Universitat Aut\u00f2noma de Barcelona, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander I.","family":"Spira","sequence":"additional","affiliation":[{"name":"Virginia Cancer Specialists, Fairfax"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girard","sequence":"additional","affiliation":[{"name":"Institut Curie, Paris"},{"name":"Paris-Saclay University, Universit\u00e9 de Versailles Saint-Quentin-en-Yvelines, Versailles, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jung","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Hoon","family":"Lee","sequence":"additional","affiliation":[{"name":"Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurii","family":"Ostapenko","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongwut","family":"Danchaivijitr","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, Siriraj Hospital Faculty of Medicine, Mahidol University Bangkok Noi Campus, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baogang","family":"Liu","sequence":"additional","affiliation":[{"name":"Harbin Medical University Cancer Hospital, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adlinda","family":"Alip","sequence":"additional","affiliation":[{"name":"Clinical Oncology Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Korbenfeld","sequence":"additional","affiliation":[{"name":"British Hospital of Buenos Aires, Central British Hospital, Buenos Aires"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Mour\u00e3o Dias","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Barretos Cancer Hospital, S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5090-8189","authenticated-orcid":false,"given":"Benjamin","family":"Besse","sequence":"additional","affiliation":[{"name":"Paris-Saclay University, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7575-3870","authenticated-orcid":false,"given":"Antonio","family":"Passaro","sequence":"additional","affiliation":[{"name":"Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Hyeong","family":"Lee","sequence":"additional","affiliation":[{"name":"Medical Department, Chungbuk National University Hospital, Cheongju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Huizhou Municipal Central Hospital of Guangdong Province, Huizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Hin","family":"How","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Respiratory Medicine, International Islamic University Malaysia Medical Specialist Center, Pahang, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cheng","sequence":"additional","affiliation":[{"name":"Jilin Cancer Hospital, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee-Chen","family":"Chang","sequence":"additional","affiliation":[{"name":"School of Medicine and Institute of Medicine, Chung Shan Medical University and Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany"},{"name":"National Center for Tumor Diseases Heidelberg, a partnership between the German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany"},{"name":"Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Nguyen","sequence":"additional","affiliation":[{"name":"City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Hong Ignatius","family":"Ou","sequence":"additional","affiliation":[{"name":"University of California, Irvine School of Medicine, Orange"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Mukhedkar","sequence":"additional","affiliation":[{"name":"St. John of God Murdoch Hospital, Murdoch, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Prabhash","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Division of Adult Solid Tumor Oncology, Tata Memorial Hospital, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manolo","family":"D\u2019Arcangelo","sequence":"additional","affiliation":[{"name":"Local Health Unit Authority of Romagna, Ravenna Hospital and Department of Onco-Hematology, Santa Maria delle Croci Hospital of Ravenna, Emilia-Romagna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Alatorre-Alexander","sequence":"additional","affiliation":[{"name":"Health Pharma Professional Research, Mexico City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"V\u00e1zquez Lim\u00f3n","sequence":"additional","affiliation":[{"name":"Oncolog\u00eda M\u00e9dica, Antiguo Hospital Civil de Guadalajara \u201cFray Antonio Alcalde\u201d and Universidad de Guadalajara, Guadalajara, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Alves","sequence":"additional","affiliation":[{"name":"Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniil","family":"Stroyakovskiy","sequence":"additional","affiliation":[{"name":"Moscow City Oncology Hospital No. 62, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Peregudova","sequence":"additional","affiliation":[{"name":"Medical Center in Kolomenskoe, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali Nahit","family":"\u015eendur","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ankara Bilkent City Hospital and Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozan","family":"Yazici","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Califano","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Guti\u00e9rrez Calder\u00f3n","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Regional Universitario de M\u00e1laga, M\u00e1laga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"de Marinis","sequence":"additional","affiliation":[{"name":"Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-We","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirish M.","family":"Gadgeel","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Owen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, McGill University Health Centre, Montreal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Xie","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Raritan, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Raritan, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9634-5630","authenticated-orcid":false,"given":"Jaydeep","family":"Mehta","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Spring House, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Venkatasubramanian","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Titusville, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariah","family":"Ennis","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Spring House, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Fennema","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Daksh","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Raritan, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Roshak","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Spring House, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Man","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Raritan, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland E.","family":"Knoblauch","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Spring House, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Bauml","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Spring House, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahadi","family":"Baig","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Raritan, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujay","family":"Shah","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Spring House, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Sethi","sequence":"additional","affiliation":[{"name":"Johnson &amp; Johnson, Spring House, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5562-270X","authenticated-orcid":false,"given":"Byoung Chul","family":"Cho","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2204.0023"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.12.009"},{"key":"e_1_3_5_4_2","unstructured":"Rybrevant (amivantamab-vmjw) injection for intravenous use. Horsham PA: Janssen Biotech 2025 (https:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/RYBREVANT-pi.pdf)."},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713137"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913662"},{"key":"e_1_3_5_7_2","first-page":"1","article-title":"First-line (1L) osimertinib (osi) \u00b1 platinum-pemetrexed in EGFR-mutated (EGFRm) advanced NSCLC: FLAURA2 post-progression outcomes.","volume":"9","author":"Valdiviezo Lama NI","year":"2024","unstructured":"Valdiviezo Lama NI, Okamoto IH, Hughes BGM, et al. First-line (1L) osimertinib (osi) \u00b1 platinum-pemetrexed in EGFR-mutated (EGFRm) advanced NSCLC: FLAURA2 post-progression outcomes. ESMO Open 2024;9:Suppl 3:1-1. abstract.","journal-title":"ESMO Open"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2021.10.020"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0573-8"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.9074"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy424.063"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1556-0864(23)00273-3"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-022-00302-w"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.07.764"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.8504"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00533"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306434"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2833"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0071"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0116"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2022.11.004"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.9008"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00662"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.11.025"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00515"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403614"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.09.026"},{"key":"e_1_3_5_28_2","unstructured":"Johnson & Johnson. European Commission approves Lazcluze (lazertinib) in combination with Rybrevant (amivantamab) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer. 2024 (https:\/\/www.jnj.com\/media-center\/press-releases\/european-commission-approves-lazcluze-lazertinib-in-combination-with-rybrevant-amivantamab-for-the-first-line-treatment-of-patients-with-egfr-mutated-advanced-non-small-cell-lung-cancer)."},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.117"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2297"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-2019-rbmlc-04"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2016.04.004"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2015.01.020"},{"key":"e_1_3_5_34_2","doi-asserted-by":"crossref","unstructured":"Girard N Li W Spira AI et al. Preventing moderate to severe dermatologic adverse events in first-line EGFR-mutant advanced NSCLC treated with amivantamab plus lazertinib: early success of the COCOON trial. J Thorac Oncol 2025;20:Suppl 1:S14-S16. abstract (https:\/\/www.jto.org\/article\/S1556-0864(25)00205-9\/fulltext).","DOI":"10.1016\/S1556-0864(25)00205-9"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2024.04.004"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2025.01.018"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.01001"},{"key":"e_1_3_5_38_2","unstructured":"Johnson & Johnson. European Commission approves subcutaneous Rybrevant (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer. 2025 (https:\/\/www.jnj.com\/media-center\/press-releases\/european-commission-approves-subcutaneous-rybrevant-amivantamab-for-the-treatment-of-patients-with-advanced-egfr-mutated-non-small-cell-lung-cancer)."}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2503001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T21:01:24Z","timestamp":1761771684000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2503001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":37,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025,10,30]]}},"alternative-id":["10.1056\/NEJMoa2503001"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2503001","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]}}}